PHONE: (414) 333-3873


  • Uncategorized

    Press Release

    - by John Reimer

    John Reimer New Vice President of Business Development for BioMed ENT


    – BioMed ENT, a prominent player in the Ear, Nose, and Throat (ENT) healthcare industry, is pleased to announce the appointment of John Reimer as the new Vice President of Business Development, overseeing its United States operations. This strategic move aligns with BioMed ENT’s vision of expanding its innovative medical solutions in the ENT space, leveraging John’s extensive experience and the collective leadership approach he cultivated at Xiogenix.

    At Xiogenix, John was part of a dynamic leadership team that included Rachel Bahr and Jerry Jendusa, from whom he gained invaluable insights. Together, they propelled Xiogenix to new heights, nurturing a culture of collaboration and innovation. This team-centric approach led to significant advancements in bioscience, particularly in tissue banking and cell therapy, showcasing the power of collective effort in achieving corporate success and industry breakthroughs.

    Tonny Voermans, President of BioMed ENT, expressed enthusiasm about John’s appointment, stating, “We are thrilled to welcome John to our team. His experience in harnessing the strength of collaborative leadership and his proven track record in the bioscience field are exactly what BioMed ENT needs to enhance our presence and impact in the U.S. ENT market.”

    In his new role, John is tasked with driving BioMed ENT’s business development initiatives in the United States, focusing on introducing innovative solutions that address the complex needs of the ENT healthcare sector. His leadership is anticipated to foster a culture of innovation and teamwork, mirroring the successful strategies employed at Xiogenix.

    “I am excited to join BioMed ENT and contribute to its mission of advancing ENT healthcare through innovation,” said John Reimer. “The opportunity to lead the U.S. operations and work with a talented team to deliver impactful solutions is incredibly motivating. I look forward to building on the collaborative leadership approach I experienced at Xiogenix to achieve great things at BioMed ENT.”

    BioMed ENT is dedicated to improving patient outcomes and enhancing the efficiency of ENT healthcare services with its cutting-edge solutions. With John Reimer at the helm of its U.S. business development, the company is poised for significant growth and continued innovation in the ENT field.